logo

For the Inventor, By the Inventor

Ferrette, France

Serge Burner

This inventor holds 6 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1992-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serge Burner. Retrieved from https://idiyas.com/inventor/serge-burner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal6 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 1992-2002

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6440995 - Quinolin-4-yl derivatives (2002-08-27),
2. 6339093 - Isoquinoline derivatives (2002-01-15),
3. 6310213 - Ethanesulfonyl-piperidine derivatives (2001-10-30),
4. 5362738 - Tricyclic pyridone derivatives (1994-11-08),
5. 5258387 - Tricyclic pyridone derivatives (1993-11-02),
6. 5143912 - Tricyclic pyridone derivatives (1992-09-01),

Title: The Innovations of Serge Burner

Introduction

Serge Burner is a notable inventor based in Durmenach-Ferrette, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate neuronal activity and plasticity. With a total of 6 patents to his name, his work continues to impact the scientific community.

Latest Patents

Among his latest patents are the Quinolin-4-yl derivatives, which include phenyl substituted quinolin 4-yl derivatives and pharmaceutical compositions with activity as NMDA-receptor subtype selective blockers. These compounds are designed to modulate neuronal activity and plasticity, showcasing his innovative approach to addressing neurological challenges.

Career Highlights

Serge Burner is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to focus on groundbreaking research and development in the field of medicinal chemistry.

Collaborations

Throughout his career, Burner has collaborated with esteemed colleagues such as Alexander Alanine and Marie-Paule Heitz Neidhart. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Serge Burner's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…